These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Epstein-Barr virus-infected T cells in infectious mononucleosis. Tokunaga M; Uemura Y; Tokudome T; Sato E Acta Pathol Jpn; 1993 Mar; 43(3):146-7. PubMed ID: 8387238 [No Abstract] [Full Text] [Related]
4. Oral excretion of Epstein-Barr virus by healthy subjects and patients with infectious mononucleosis. Gerber P; Lucas S; Nonoyama M; Perlin E; Goldstein LI Lancet; 1972 Nov; 2(7785):988-9. PubMed ID: 4116980 [No Abstract] [Full Text] [Related]
5. The lymphocyte in infections with Epstein-Barr virus and cytomegalovirus. Ho M J Infect Dis; 1981 Jun; 143(6):857-62. PubMed ID: 6265567 [No Abstract] [Full Text] [Related]
6. Monoclonal proliferation of T cells containing Epstein-Barr virus in fatal mononucleosis. Mori M; Kurozumi H; Akagi K; Tanaka Y; Imai S; Osato T N Engl J Med; 1992 Jul; 327(1):58. PubMed ID: 1317943 [No Abstract] [Full Text] [Related]
8. Epstein-Barr virus and infectious mononucleosis. Henle W; Henle G N Engl J Med; 1973 Feb; 288(5):263-4. PubMed ID: 4345065 [No Abstract] [Full Text] [Related]
9. Absence of infectious Epstein-Barr virus in blood in acute infectious mononucleosis. Rickinson AB; Epstein MA; Crawford DH Nature; 1975 Nov; 258(5532):236. PubMed ID: 172793 [No Abstract] [Full Text] [Related]
10. The MLC response of patients with infectious mononucleosis to Epstein-Barr virus-transformed cells. Wasik M; Myc A; Matej H; Rudzka L Arch Immunol Ther Exp (Warsz); 1983; 31(6):871-8. PubMed ID: 6331340 [TBL] [Abstract][Full Text] [Related]
11. Quantitative evaluation of Epstein-Barr-virus-infected mononuclear peripheral blood leukocytes in infectious mononucleosis. Rocchi G; Felici A; Ragona G; Heinz A N Engl J Med; 1977 Jan; 296(3):132-4. PubMed ID: 187934 [TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphism of natural Epstein-Barr virus isolates from infectious mononucleosis patients and healthy carriers. Lung ML; Chang RS; Jones JH J Virol; 1988 Oct; 62(10):3862-6. PubMed ID: 2901499 [TBL] [Abstract][Full Text] [Related]
13. Prolonged oropharyngeal excretion of Epstein-Barr virus after infectious mononucleosis. Miller G; Niederman JC; Andrews LL N Engl J Med; 1973 Feb; 288(5):229-32. PubMed ID: 4345064 [No Abstract] [Full Text] [Related]
14. Neutralizing antibodies to Epstein-Barr virus in healthy populations and patients with infectious mononucleosis. Hewetson JF; Rocchi G; Henle W; Henle G J Infect Dis; 1973 Sep; 128(3):283-9. PubMed ID: 4353929 [No Abstract] [Full Text] [Related]
15. Role of Epstein-Barr virus in infectious mononucleosis and malignant lymphomas in man. Henle W Fed Proc; 1972; 31(6):1674. PubMed ID: 4351377 [No Abstract] [Full Text] [Related]
16. Activation of suppressor T cells during Epstein-Barr-virus-induced infectious mononucleosis. Tosato G; Magrath I; Koski I; Dooley N; Blaese M N Engl J Med; 1979 Nov; 301(21):1133-7. PubMed ID: 226884 [TBL] [Abstract][Full Text] [Related]
17. Letter: Epstein-Barr viral antibodies and leukocyte-transforming agent in infectious mononucleosis. Chang RS; Cooper TY; Simpson EE N Engl J Med; 1976 Jun; 294(25):1404-5. PubMed ID: 177877 [No Abstract] [Full Text] [Related]
18. [The Epstein-Barr Virus and Infectious Mononucleosis. Findings, interpretations, and an alternative hypothesis on the direct etiology by the Epstein-Barr Virus]. Gsell HO Schweiz Med Wochenschr; 1971 Jun; 101(23):841-8. PubMed ID: 4325374 [No Abstract] [Full Text] [Related]